ADMA Stock News & Analysis | Latest Updates

ADAMA Continues Upward Trend in ESG Performance, Ranked in the Top Quartile of the Industry in Latest EcoVadis Rating

Marks fifth consecutive year of improvement, ranking in the top 23% of the Manufacture of Pesticides and Other Agrochemical Products industry – including top 14% for environment and top 5% for ethics BEIJING and TEL AVIV, Israel, Aug. 12, 2025 /PRNewswire/ -- ADAMA Ltd. (SZSE: 000553), a...

August 13, 2025ESG

ADMA News

ADAMA Continues Upward Trend in ESG Performance, Ranked in the Top Quartile of the Industry in Latest EcoVadis Rating

ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update

How Is The Market Feeling About ADMA Biologics?

Raymond James Maintains Strong Buy on ADMA Biologics, Raises Price Target to $32

Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings

ADMA Biologics FY2026 Revenue expected to be more than $625.00M vs $629.23M Est

ADMA Biologics FY2025 Revenue expected to be more than $500.00M vs $495.10M Est

ADMA Biologics Q1 Adj. EPS $0.14 Misses $0.16 Estimate, Sales $114.80M Miss $116.40M Estimate

ADMA Biologics Earnings Preview

What's Going On With ADMA Stock Monday?

Cemex Posts Q1 Results, Joins Plug Power, Sabre And Other Big Stocks Moving Higher On Monday

ADMA Biologics Announces FDA Approval Of Its Yield Enhancement Production Process

ADMA Highlights US-Based Supply Chain as Key Advantage in Tariff Era

What's Driving the Market Sentiment Around ADMA Biologics?

ADMA Biologics Option Alert: May 16 $19 Calls Sweep (5) Near The Ask: 1200 @ $2.3 vs 2667 OI; Earnings 5/8 After Close [est] Ref=$19.7

What's Driving the Market Sentiment Around ADMA Biologics?

Cantor Fitzgerald Reiterates Overweight on ADMA Biologics, Maintains $25 Price Target

ADMA Biologics Q4 2024 Adj. EPS $0.14 Misses $0.15 Estimate

ADMA Biologics Sees FY25 Total Revenue $490M+, Sees FY26 Total Revenue $605M+

ADMA Biologics Q4 2024 GAAP EPS $0.46, Sales $117.549M Beat $112.800M Estimate

Earnings Scheduled For March 3, 2025

ADMA Reports 2024 Preliminary Revenue Of $ $417M-425M ($422.39M Est.) With With Over $100M Cash, Projects FY 2025 Revenue Over $485M And FY 2026 Above $600M

Amazon Posts Upbeat Results, Joins Cardinal Health, Waters, Atlassian, Charter Communications, MasTec And Other Big Stocks Moving Higher On Friday